Skip to main content
Erschienen in: Quality of Life Research 3/2020

28.11.2019

Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies

verfasst von: Kathrin Sommer, Francesco Cottone, Neil K. Aaronson, Peter Fayers, Paola Fazi, Gianantonio Rosti, Emanuele Angelucci, Gianluca Gaidano, Adriano Venditti, Maria Teresa Voso, Michele Baccarani, Marco Vignetti, Fabio Efficace

Erschienen in: Quality of Life Research | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To ensure that observed differences in the scores of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) reflect actual differences in health-related quality of life (HRQoL) rather than measurement bias, measurement invariance needs to be established. We investigated the assumption of measurement invariance of the EORTC QLQ-C30 in patients with hematological malignancies across age, sex, comorbidity, disease type, and time.

Methods

We used a large database of patients with hematological malignancies, which included HRQoL data collected with the EORTC QLQ-C30. We used the structural equation modeling approach to test for measurement (metric and scalar) invariance across groups (age, sex, comorbidity, disease) and time (baseline, 1 month and 2 month follow-up). Longitudinal invariance was examined in a subgroup of patients diagnosed with myelodysplastic syndromes.

Results

Confirmatory factor analyses demonstrated full measurement invariance for age and comorbidity and over time, while support for partial scalar invariance was obtained for sex and disease. Violations of invariance for sex were observed for items of the physical functioning scale and the emotional functioning scale, while for disease type, violations of invariance were observed for items of the physical functioning scale, emotional functioning scale, and the cognitive functioning scale.

Conclusions

Our findings support measurement invariance of the EORTC QLQ-C30 in a large sample of patients with hematological malignancies. The results showed that the number of non-invariant items was negligible, suggesting that this questionnaire is a valid and robust measurement tool in patients with hematological malignancies, also for comparisons across groups and time.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute,85(5), 365–376.CrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute,85(5), 365–376.CrossRef
3.
Zurück zum Zitat Cocks, K., King, M. T., Velikova, G., de Castro, G., Martyn St-James, M., Fayers, P. M., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer,48(11), 1713–1721. https://doi.org/10.1016/j.ejca.2012.02.059.CrossRefPubMed Cocks, K., King, M. T., Velikova, G., de Castro, G., Martyn St-James, M., Fayers, P. M., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer,48(11), 1713–1721. https://​doi.​org/​10.​1016/​j.​ejca.​2012.​02.​059.CrossRefPubMed
14.
Zurück zum Zitat Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). EORTC QLQ-C30 scoring manual (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer. Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). EORTC QLQ-C30 scoring manual (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer.
18.
Zurück zum Zitat Schermelleh-Engel, K., Moosbrugger, H., & Müller, H. (2003). Evaluating the fit of structural equation models: Tests of significance and descriptive goodness-of-fit measures. Methods of Psychological Research,8(2), 23–74. Schermelleh-Engel, K., Moosbrugger, H., & Müller, H. (2003). Evaluating the fit of structural equation models: Tests of significance and descriptive goodness-of-fit measures. Methods of Psychological Research,8(2), 23–74.
20.
Zurück zum Zitat Bollen, K. A. (1989). Structural equations with latent variables. Wiley series in probability and mathematical statistics. New York: Wiley. Bollen, K. A. (1989). Structural equations with latent variables. Wiley series in probability and mathematical statistics. New York: Wiley.
35.
Zurück zum Zitat Fayers, P. M., & Hand, D. J. (1997). Factor analysis, causal indicators and quality of life. Quality of Life Research,6(2), 139–150.CrossRef Fayers, P. M., & Hand, D. J. (1997). Factor analysis, causal indicators and quality of life. Quality of Life Research,6(2), 139–150.CrossRef
Metadaten
Titel
Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies
verfasst von
Kathrin Sommer
Francesco Cottone
Neil K. Aaronson
Peter Fayers
Paola Fazi
Gianantonio Rosti
Emanuele Angelucci
Gianluca Gaidano
Adriano Venditti
Maria Teresa Voso
Michele Baccarani
Marco Vignetti
Fabio Efficace
Publikationsdatum
28.11.2019
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 3/2020
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-019-02369-5

Weitere Artikel der Ausgabe 3/2020

Quality of Life Research 3/2020 Zur Ausgabe